4 analysts have shared their evaluations of 4D Molecular Therapeutics (NASDAQ:FDMT) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below offers a ...
FOR more info, visit the PCSO 4D Lotto page.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback